As of the close of the 2021-22 legislative session, Governor Gavin Newsom signed into law health care related legislation tackling issues from management of health care costs to reproductive rights. In Part I of our legislative update, we summarize many of the laws relevant to licensed health care professionals.
Physicians & Surgeons
AB 1278: California Licensed Physicians and Surgeons or their Employers Must Provide Notice to Patients of the Open Patients Database
Effective January 1, 2023, California licensed physicians and surgeons or their employers must provide to each patient at the initial office visit written or electronic notice of the Open Payments database (a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals) and retain the notice in the patient’s medical record. Written notice must include a signature from the patient or patient’s representative and the date of signature. Additionally, physicians must post an Open Payments database notice in each location where they practice in an area likely to be seen by all persons who enter the location. Beginning January 1, 2024, if a physician’s practice maintains an internet website, then the website must include an Open Payments database notice. Physicians and surgeons who do not follow the new law may be disciplined by their respective licensing boards for unprofessional conduct. See our recent post for more detail on the new law’s requirements here.
AB 1954: Physicians and Surgeons May Not Automatically Deny Treatment to Qualified Patients Based Solely on a Positive Drug Screen for Tetrahydrocannabinol THC
Effective January 1, 2023, physicians are prohibited from automatically denying treatment or medication to a “qualified patient” under California’s Compassionate Use Act based solely on a positive drug screen for THC or report of medical cannabis use without first completing a case-by-case evaluation of the patient that includes a determination that the qualified patient’s use of medical cannabis is “medically significant” to the treatment or medication. Use of medical cannabis that has been recommended by a licensed physician will not constitute the use of an illicit substance for purposes of such an evaluation. Physicians will not be punished, or denied any right or privilege, for having administered treatment or medication to a qualified patient consistent with the new law and consistent with the standard of care.
AB-2098: A Physician’s or Surgeon’s Dissemination of Misinformation Related to COVID-19 Is Unprofessional Conduct
Effective January 1, 2023, disseminating misinformation or disinformation related to COVID-19, including false or misleading information regarding the nature and risks of the virus, its prevention and treatment, and the development, safety, and effectiveness of COVID-19 vaccines by physicians is unprofessional conduct.
SB 1375: Nurse Practitioners and Nurse Midwives May Perform First-Trimester Abortions Following Completion of Required Training
Effective January 1, 2023, nurse practitioners and nurse-midwives who have completed specified training are authorized to perform an abortion within the first trimester of pregnancy by aspiration techniques under standardized protocols under physician supervision or independently if the nurse practitioner has met the requirements for independent practice in California. The bill requires a nurse practitioner to practice abortion by aspiration techniques consistent with applicable standards of care and within the scope of the nurse practitioner’s clinical and professional education and training.
AB 2754: Registered Psychological Associates May Be Supervised Via Synchronous Audiovisual Means
Effective immediately, AB 2754 authorizes the supervision of an applicant for licensure as a psychologist, and of a registered psychological associate, to be provided in real time, which is defined as through in-person or synchronous audiovisual means, in compliance with federal and state laws related to patient health confidentiality.
AB 2574: Optometrists May Used Tests Performed in CLIA-Waived Labs and Administer Certain Immunizations
Effective January 1, 2023, among other things, the new law clarifies and expands the scope of optometry by authorizing optometrists to use laboratory tests or examinations performed in a laboratory with a certificate of waiver; and administer various immunizations including COVID-19 vaccinations if certain requirements are met.
SB 1259: Pharmacists May Furnish FDA-Approved Opioid Antagonists
Effective January 1, 2023, pharmacists who complete required training are authorized to furnish an opioid antagonist approved by the federal Food and Drug Administration (instead of only naloxone hydrochloride) in accordance with standardized procedures or protocols developed and approved by both the California State Board of Pharmacy and the Medical Board of California, in consultation with the California Society of Addiction Medicine, the California Pharmacists Association, and other appropriate entities.
AB 852: Practitioners Must Follow New Rules Regarding Electronic Prescriptions
Effective January 1, 2023, a pharmacy, pharmacist, or other practitioner authorized to dispense or furnish a prescription is prohibited from refusing to dispense or furnish an electronic prescription solely because the prescription was not submitted via, or is not compatible with, their proprietary software. However, a pharmacy, pharmacist, or other authorized practitioner may decline to dispense or furnish an electronic prescription submitted via software that fails to meet any one of specified criteria, including compliance with the federal Health Insurance Portability and Accountability Act of 1996.
Also, the new law adds the following exemptions from the requirement that prescriptions be issued as an electronic data transmission prescription:
- Prescriptions issued by a prescribing health care practitioner serving as a volunteer in a free clinic who receives no remuneration for their services; and
- A prescriber who has registered with the California State Board of Pharmacy in a manner and format determined by the board, stating that they are located in the area of a declared disaster or emergency; issue 100 or fewer prescriptions per year; or are unable to issue electronic data transmission prescriptions due to circumstances beyond their control.
Further, the new law specifies the following exceptions to the requirement that a pharmacy immediately transfer an electronic prescription to an alternative pharmacy upon request of the patient:
- The action would result in a violation of any state or federal law; and
- The action is not supported by the latest version of the National Council for Prescription Drug Programs SCRIPT standard.
If a pharmacy is prohibited from transferring or forwarding electronic data transmission prescriptions, and that prohibition is subsequently removed, then that pharmacy shall implement, within one year from the date the prohibition is removed, the necessary provisions to allow for the transferring or forwarding of an electronic data transmission prescription.
Stay tuned for the next installment of our blog series on California legislative updates for the 2021-22 legislative session!